|
WO2021048748A1
|
|
Pharmaceutical formulations comprising diclofenac
|
|
WO2020188457A1
|
|
Solutions for oral dosage
|
|
US2020188478A1
|
|
Pre-mixed, ready to use vancomycin compositions
|
|
WO2020053665A2
|
|
Non-aqueous chemotherapeutic suspensions for oral dosage
|
|
WO2020053662A2
|
|
Non-aqueous solutions for oral dosage
|
|
WO2020053658A2
|
|
Non-aqueous chemotherapeutic solutions for oral dosage
|
|
WO2020044114A2
|
|
Methotrexate pharmaceutical composition
|
|
US2021059967A1
|
|
Liquid parenteral compositions of levothyroxine
|
|
WO2020039263A2
|
|
Pharmaceutical suspension for oral dosage
|
|
GB202103724D0
|
|
Pharmaceuticals solution for oral dosage
|
|
WO2020039264A2
|
|
Chemotherapeutic pharmaceutical suspension for oral dosage
|
|
US2019290718A1
|
|
Composition comprising bortezomib
|
|
WO2019186515A1
|
|
Liquid pharmaceutical compositions of antiepileptic drugs
|
|
US2021030671A1
|
|
Liquid dosage forms of cinacalcet or salt thereof
|
|
WO2019162756A2
|
|
Liquid pharmaceutical compositions of anticancer drugs
|
|
EP3735222A1
|
|
Liquid compositions of aprepitant
|
|
AU2018397436A1
|
|
Liquid oral formulations for PDE V inhibitors
|
|
WO2019038586A1
|
|
Pharmaceutical composition of melatonin
|
|
EP3668508A1
|
|
An oral pharmaceutical composition comprising zonisamide and process of preparation thereof
|
|
EP3658190A1
|
|
Liquid dosage forms of imatinib
|
